|
Good relations with the media, with private investors, and with shareholders are essential for a modern life science venture. How do you communicate your company's message if your technology is controversial or raises difficult societal and ethical issues? What is the best way to disclose sensitive information, such as a clinical failure of a product, that may send your investors stampeding for the exit? Here, experts offer advice on communicating company information clearly and effectively to the outside world.
Why media relations matter
March 2006
There is a common misperception that only medium- and large-cap biotechs need to understand and interact with the media. As investor demands increase and partnering dynamics evolve, startups need to understand the art of media relations more now than ever before.
Communicating your way through a merger—tales from the front line
July 2003
Winning the hearts and minds of stakeholders is key to a successful transaction.
A primer for website design
April 2003
Partly art, partly science, good website design is important for fledgling biotech companies.
Assets for mastering media relations
February 2003
Biotechnology startups face unique choices and challenges in public relations.
Dealing with the media
June 2002
Chris Gardner and Pam Pickering argue that whether you like it or not, good relations with the media are essential for getting your company's message across.
 more articles
|
